Barbara Sladek – Biome Diagnostics | BiomeDx

Poster: World Congress of Lung Cancer 2022

Barbara Sladek — Wed, 05 Oct 2022 12:05:01 +0000

VIENNA, October 5th: The World Congress of Lung Cancer is the world’s largest international gathering of clinicians, researchers and scientists in the field of lung cancer and thoracic oncology (https://wclc2022.iaslc.org). We could not have chosen a better stage to introduce BiomeOne® for the first time. This work provides an insight into the development of the intestinal microbiome…

Source

Biome Diagnostics wins EY ScaleUp Award BioTech & Healthcare

Barbara Sladek — Sun, 12 Jun 2022 18:25:28 +0000

VIENNA, June 2022 Exciting times for Biome Diagnostics! The company has been awarded with the prestigious EY ScaleUp Award of the Year 2022 in the category BioTech and Healthcare! This means a lot since it shows outstanding the company is! What a great achievement of the entire time! Read more (German): https://www.ey.com/de_at/start-ups/oesterreichs-scale-up-des-jahres-2022…

Source

Female Entrepreneur of the Year

Barbara Sladek — Sun, 12 Jun 2022 18:01:03 +0000

VIENNA, May 2022 Our Co-Founder, Dr. Barbara Sladek, has been awarded the Female Entrepreneur of the Year 2022 in the category “innovation” by the Austrian Chambers of Commerce and the newspaper DiePresse. Read the full article here: https://lnkd.in/gZivCwTy (German)…

Source

BiomeDx at the semi-finals of the EIT Health Catapult

Barbara Sladek — Fri, 03 Jun 2022 09:11:36 +0000

VIENNA, May 2022 We are pleased to announce that we are among the winners of the DACH regionals 2022 of EIT Health Catapult programme! EIT Health Catapult is a training and competition programme that boosts the development of top-notch European health start-ups (Biotech, MedTech and Digital Health) through exposure to leading experts and international investors. We are proud and…

Source

How to „Medizinproduktzertifizierung“?

Barbara Sladek — Tue, 17 May 2022 12:09:17 +0000

VIENNA, May 2022 To reach the market, MedTech companies need to know how to navigate the world of EU-regulations, and in particular those that aim to obtain the CE-IVD certification of their in vitro diagnostic solutions. Our co-founder, Nikolaus Gasche, gave an interview to Healthcare Startups Deutschland regarding our journey throughout this certification process…

Source

Potential through personalized cancer therapy

Barbara Sladek — Wed, 11 May 2022 18:18:08 +0000

VIENNA, May 2022 The magazine “Doctors today” highlights the importance of personalized cancer therapy. BiomeOne will play a major role in achieving that! We are excited to announce the launch of BiomeOne very soon!

Source

How Big Data is driving personalised cancer therapy

Barbara Sladek — Wed, 11 May 2022 18:04:19 +0000

VIENNA, May 2022 Our co-founder, Barbara Sladek published a guest article in the magazine Healthcare Computing, highlighting the fundamental role of BigData for the development of AI-based tools that allow modern & precise analysis of the intestinal microbiome. Such tools open the door to a world of possibilities, including our mission at Biome Diagnostics: that of harnessing the power of…

Source

BiomeDx among 11 Start Ups to watch out in Austria!

Barbara Sladek — Wed, 11 May 2022 17:47:13 +0000

VIENNA, May 2022 The Vienna Business Agency and Sifted shared an article about how women are making waves in the Vienna tech scene! We are proud and grateful to be named as 1 of the 11 startups to watch out for in Austria! Sifted Article: https://sifted.eu/articles/11-vienna-female-founders-austria-entrepreneurship/

Source

Diversity leads to resilience

Barbara Sladek — Wed, 11 May 2022 17:10:21 +0000

VIENNA, February 2022: In February and March 2022 Biome Diagnostics got featured in the Magazine “Niedergelassener Arzt” and “CliniCum:onko”. This coverage makes us proud and happy, because it also verifies, that we are on the right track towards a biomarker based on the intestinal microbiome. Read the article in English: Diversity leads to resilience Recent studies have shown that…

Source

One, two, reset: how can gut microbes change the fate of immunotherapy

Barbara Sladek — Thu, 03 Feb 2022 10:37:26 +0000

VIENNA, January 2022 Using feces to fight cancer Yes — you read it correctly. Scientists and doctors are using feces to put an end to cancer. Translating it into scientific terms, it consists of a fecal microbiota transplant (or shortly, FMT) from a healthy donor or from patients that have previously responded positively to immunotherapy.

Source